The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population

References

• Chey WD. New insights in IBS-C and chronic constipation: an interview with William D. Chey, MD, AGAF, FACG, FACP. Medscape Gastroenterol 2006;8(1). Available at: http://www.medscape.org/viewarticle/532440 [Last accessed 5 May 2014]
   Google Scholar
• Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91
   PubMed Web of Science ®Google Scholar
• American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 2005;100(Suppl):S1-4
   Google Scholar
• Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2012;10:712-21.e4
   PubMed Web of Science ®Google Scholar
• Stelwagon M, Chey W, Olden K, et al. symptom frequency, health care seeking behavior and satisfaction with therapy among IBS-C patients meeting Rome II Criteria: results of a population-based survey. Las Vegas, NV: American Academy of Nurse Practitioners (AANP), 2011
   Google Scholar
• Higgins PDR, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004;99:750-9
   PubMed Web of Science ®Google Scholar
• Schoenfeld P. Symptom frequency, health care seeking behavior, and satisfaction with therapy among chronic constipation patients: results of a population-based survey. San Antonio, Texas, USA, Poster Presentation at ACG; 2010
   Google Scholar
• Eoff JC. optimal treatment of chronic constipation in managed care: review and roundtable discussion. J Manag Care Pharm 2008;14(9 Supplement A):1-15
   Google Scholar
• Sun SX, Dibonaventura M, Purayidathil FW, et al. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of The National Health And Wellness Survey. Digest Dis Sci 2011;56:2688-95
   PubMed Web of Science ®Google Scholar
• DiBonaventura M, Sun SX, Bolge SC, et al. Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome. Curr Med Res Opin 2011;27:2213-22
   PubMed Web of Science ®Google Scholar
• Cai Q, Buono JL, Spalding WM, et al. Economic burden of Irritable Bowel Syndrome with constipation: a retrospective cohort study in a commercially insured population. Presented at ACG Annual Scientific Meeting. Las Vegas, NV; October 19, 2012
   Google Scholar
• Cai Q, Buono JL, Spalding WM, et al. Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population. J Med Econ 2014;17:148-58
   Google Scholar
• Spiller R, Aziz Q, Creed F, et al. Guidelines on the Irritable Bowel Syndrome: mechanisms and practical management. Gut 2007;56:1770-98
   PubMed Web of Science ®Google Scholar
• Levy RL, Von Korff M, Whitehead WE, et al. Costs of care for Irritable Bowel Syndrome patients in a health maintenance organization. Am J Gastroenterol 2001;96:3122-9
   PubMed Web of Science ®Google Scholar
• Ricci J. Costs of care for Irritable Bowel Syndrome in managed care. JCOM 2000;7:23-8
   Google Scholar
• Leong SA, Barghout V, Birnbaum HG, et al. The economic consequences Of Irritable Bowel Syndrome: a US employer perspective. Arch Intern Med 2003;163:929-35
   PubMed Web of Science ®Google Scholar
• Patel R, Petitta A, Fogel R, et al. The economic impact of irritable bowel syndrome in a managed care setting. J Clin Gastroenterol 2002;35:14-20
   PubMed Web of Science ®Google Scholar
• Mitra D, Davis KL, Baran RW. All-cause health care charges among managed care patients with constipation and comorbid Irritable Bowel Syndrome. Postgrad Med 2011;123:122-32
   PubMed Web of Science ®Google Scholar
• Nyrop KA, Palsson OS, Levy RL, et al. Costs of health care for Irritable Bowel Syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Therapeut 2007;26:237-48
   PubMed Web of Science ®Google Scholar
• Frissora CL, Koch KL. Symptom overlap and comorbidity of Irritable Bowel Syndrome with other conditions. Curr Gastroenterol Rep 2005;7:264-71
   PubMedGoogle Scholar
• Pimentel M, Park S, Mirocha J, et al. The effect of a nonabsorbed oral antibiotic (Rifaximin) on the symptoms of The Irritable Bowel Syndrome: a randomized trial. Ann Intern Med 2006;145:557-63
   PubMed Web of Science ®Google Scholar
• Ramkumar D, Rao SSC. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am Gastroenterol 2005;100:936-71
   PubMed Web of Science ®Google Scholar
• Lembo A, Camilleri M. Chronic constipation. N Engl J Med 2003;349:1360-8
   PubMed Web of Science ®Google Scholar
• Khawaja MR, Akhavan N, Chiorean M. Chronic constipation with megacolon. J Gen Intern Med 2011;26:938
   Google Scholar
• Pemberton JH, Rath DM, Ilstrup DM. evaluation and surgical treatment of severe chronic constipation. Ann Surg 1991;214:403-11; discussion 411-3
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
   Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9
   PubMed Web of Science ®Google Scholar